GE HealthCare Technologies Net Profit Margin 2020-2024 | GEHC
GE HealthCare Technologies Net Profit Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Net Income | Net Margin |
2024-03-31 | $19.50B | $1.57B | 8.05% |
2023-12-31 | $19.55B | $1.39B | 7.08% |
2023-09-30 | $19.28B | $1.54B | 7.97% |
2023-06-30 | $19.04B | $1.65B | 8.66% |
2023-03-31 | $18.71B | $1.72B | 9.17% |
2022-12-31 | $18.34B | $1.92B | 10.45% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $34.790B | $19.552B |
Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Inspire Medical Systems (INSP) | United States | $7.322B | 0.00 |
10x Genomics (TXG) | United States | $3.489B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.410B | 0.00 |
Axonics (AXNX) | United States | $3.396B | 0.00 |
Enovis (ENOV) | United States | $3.029B | 23.01 |
Azenta (AZTA) | United States | $2.925B | 238.46 |
Olink Holding AB (publ) (OLK) | Sweden | $2.864B | 0.00 |
Hims & Hers Health (HIMS) | United States | $2.685B | 0.00 |
Privia Health (PRVA) | United States | $2.183B | 96.84 |
Schrodinger (SDGR) | United States | $1.763B | 0.00 |
Omnicell (OMCL) | United States | $1.231B | 30.12 |
Phreesia (PHR) | United States | $1.169B | 0.00 |
Definitive Healthcare (DH) | United States | $0.817B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.783B | 0.00 |
Standard BioTools (LAB) | United States | $0.719B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.608B | 0.00 |
Talkspace (TALK) | United States | $0.519B | 0.00 |
Health Catalyst (HCAT) | United States | $0.367B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.333B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.312B | 0.00 |
Pulmonx (LUNG) | United States | $0.293B | 0.00 |
P3 Health Partners (PIII) | United States | $0.170B | 0.00 |
Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
American Well (AMWL) | United States | $0.148B | 0.00 |
MSP Recovery (LIFW) | United States | $0.139B | 0.00 |
Augmedix (AUGX) | United States | $0.133B | 0.00 |
Outset Medical (OM) | United States | $0.131B | 0.00 |
TruBridge (TBRG) | United States | $0.116B | 4.94 |
111 (YI) | China | $0.087B | 0.00 |
Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.071B | 0.00 |
HeartBeam (BEAT) | United States | $0.053B | 0.00 |
Zepp Health (ZEPP) | China | $0.052B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.047B | 0.00 |
Movano (MOVE) | United States | $0.044B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
Akili (AKLI) | United States | $0.031B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.025B | 0.00 |
Cue Health (HLTH) | United States | $0.022B | 0.00 |
CareCloud (CCLD) | United States | $0.018B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.018B | 0.00 |
ETAO (ETAO) | United States | $0.016B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
Biotricity (BTCY) | United States | $0.013B | 0.00 |
Transgenomic (PRPO) | United States | $0.008B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Syra Health (SYRA) | United States | $0.006B | 0.00 |
Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |